MALMED: Vaksinat PRIORIX, t\u00eb t\u00ebrhequra nga Sht\u00ebpit\u00eb e Sh\u00ebndetit sipas Ligjit t\u00eb Barnave dhe e Pajisjeve Mjek\u00ebsore, duhet t\u00eb asgj\u00ebsohen<\/p>\n
Agjencia i Barnave dhe e Pajisjeve Mjek\u00ebsore (MALMED) informon se gjat\u00eb kontrollave n\u00eb Sht\u00ebpit\u00eb e Sh\u00ebndetit jan\u00eb gjetur 624 pako me vaksina PRIORIX (PRIORIKS) t\u00eb prodhuesit GlaxoSmithKline Biologicals S.A.- Rinsensart, Belgjik\u00eb me deklarime t\u00eb gabuara, por afati i vaksin\u00ebs, edhe n\u00eb paketimin e brendsh\u00ebm, \u00ebsht\u00eb n\u00eb rregull dhe jan\u00eb t\u00eb sigurta. Me t\u00ebrheqjen e vaksin\u00ebs nga Sht\u00ebpit\u00eb e Sh\u00ebndetit, duke u mb\u00ebshtetur n\u00eb Ligjin p\u00ebr Barna dhe e Pajisje Mjek\u00ebsore, n\u00eb p\u00ebrputhje me nenin 16 paragrafi 1 pika 5, kjo vaksin\u00eb konsiderohet si bar q\u00eb nuk \u00ebsht\u00eb p\u00ebr p\u00ebrdorim. P\u00ebr k\u00ebt\u00eb shkak MALMED-i miratoi vendim p\u00ebr t\u00eb asgj\u00ebsuar sasit\u00eb e k\u00ebsaj vaksine.<\/p>\n
MALMED-i ka v\u00ebrtetuar se n\u00eb pikat e imunizimit n\u00eb Sht\u00ebpit\u00eb e Sh\u00ebndetit Publik n\u00eb Republik\u00ebn e Maqedonis\u00eb, ka mosp\u00ebrputhje t\u00eb dh\u00ebnash p\u00ebr k\u00ebto vaksina n\u00eb lidhje me numrin serik dhe afatin e p\u00ebrdorimit t\u00eb sh\u00ebnuar n\u00eb paketimin origjinal t\u00eb jasht\u00ebm dhe t\u00eb kontaktit t\u00eb barit nga prodhuesi, si dhe n\u00eb etiket\u00ebn e ngjitur n\u00eb paketimin e jasht\u00ebm t\u00eb barit, q\u00eb p\u00ebrmban t\u00eb dh\u00ebna t\u00eb shkruara n\u00eb gjuh\u00ebn maqedonase. Kjo \u00ebsht\u00eb n\u00eb kund\u00ebrshtim me nenin 85 t\u00eb Ligjit p\u00ebr Barna dhe Pajisje Mjek\u00ebsore. Edhe nj\u00eb shkelje e ligjit n\u00eb baz\u00eb t\u00eb t\u00eb cilit, k\u00ebto vaksina patjet\u00ebr duhet t\u00eb t\u00ebrhiqen nga Sht\u00ebpit\u00eb e Sh\u00ebndetit edhe pse kan\u00eb afat.<\/p>\n
Duke i pasur parasysh dispozitat ligjore t\u00eb lartp\u00ebrmendura, sasit\u00eb e t\u00ebrhequra t\u00eb barit PRIORIX (PRIORIKS) jan\u00eb me etiket\u00eb t\u00eb gabuar dhe nuk mund t\u00eb lejohet p\u00ebrdorimi, prandaj, t\u00eb nj\u00ebjtat do t\u00eb asgj\u00ebsohen n\u00eb p\u00ebrputhje me nenin 146 paragrafi 1 pika 4 t\u00eb ligjit, sipas t\u00eb cilit inspektori farmaceutik, i cili e ka kryer mbik\u00ebqyrjen e barnave, ka t\u00eb drejt\u00eb dhe detyr\u00eb t\u00eb urdh\u00ebrojn\u00eb asgj\u00ebsimin e barit t\u00eb parregullt, n\u00eb p\u00ebrputhje me rregullat e mbrojtjes s\u00eb mjedisit jet\u00ebsor.<\/p>\n
<\/p>\n
<\/p>\n
<\/p>","protected":false},"excerpt":{"rendered":"
\u041c\u0410\u041b\u041c\u0415\u0414: \u0412\u0430\u043a\u0446\u0438\u043d\u0438\u0442\u0435 PRIORIX\u00a0\u043f\u043e\u0432\u043b\u0435\u0447\u0435\u043d\u0438 \u043e\u0434 \u0417\u0434\u0440\u0430\u0432\u0441\u0442\u0432\u0435\u043d\u0438\u0442\u0435 \u0434\u043e\u043c\u043e\u0432\u0438 \u0441\u043f\u043e\u0440\u0435\u0434\u00a0\u0417\u0430\u043a\u043e\u043d\u043e\u0442 \u0437\u0430 \u043b\u0435\u043a\u043e\u0432\u0438 \u0438 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u0430, \u0442\u0440\u0435\u0431\u0430 \u0434\u0430 \u0441\u0435 \u0443\u043d\u0438\u0448\u0442\u0430\u0442 \u0410\u0433\u0435\u043d\u0446\u0438\u0458\u0430\u0442\u0430 \u0437\u0430 \u043b\u0435\u043a\u043e\u0432\u0438 \u0438 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438 \u0441\u0440\u0435\u0434\u0441\u0442\u0432\u0430 (\u041c\u0410\u041b\u041c\u0415\u0414) \u0438\u043d\u0444\u043e\u0440\u043c\u0438\u0440\u0430 \u0434\u0435\u043a\u0430 \u043f\u0440\u0438 \u043a\u043e\u043d\u0442\u0440\u043e\u043b\u0438\u0442\u0435 \u0432\u043e \u0437\u0434\u0440\u0430\u0432\u0441\u0442\u0432\u0435\u043d\u0438\u0442\u0435 \u0434\u043e\u043c\u043e\u0432\u0438 \u0431\u0435\u0430 \u043f\u0440\u043e\u043d\u0430\u0458\u0434\u0435\u043d\u0438 624 \u043a\u0443\u0442\u0438\u0438 \u043d\u0430 \u0432\u0430\u043a\u0446\u0438\u043d\u0438 PRIORIX (\u041f\u0420\u0418\u041e\u0420\u0418\u041a\u0421) \u043e\u0434 \u043f\u0440\u043e\u0438\u0437\u0432\u043e\u0434\u0438\u0442\u0435\u043b\u043e\u0442 GlaxoSmithKline Biologicals S.A. – \u0420\u0438\u043d\u0441\u0435\u043d\u0441\u0430\u0440\u0442, \u0411\u0435\u043b\u0433\u0438\u0458\u0430 \u0441\u043e \u043f\u043e\u0433\u0440\u0435\u0448\u043d\u0438 \u0434\u0435\u043a\u043b\u0430\u0440\u0430\u0446\u0438\u0438, \u043d\u043e \u0440\u043e\u043a\u043e\u0442 \u043d\u0430 \u0441\u0430\u043c\u0430\u0442\u0430 \u0432\u0430\u043a\u0446\u0438\u043d\u0430 \u0438 […]<\/p>","protected":false},"author":2,"featured_media":68,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[42,16,10],"tags":[],"class_list":["post-2925","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pacienti","category-16","category-10"],"_links":{"self":[{"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/posts\/2925","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/comments?post=2925"}],"version-history":[{"count":0,"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/posts\/2925\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/media\/68"}],"wp:attachment":[{"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/media?parent=2925"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/categories?post=2925"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/malmed.gov.mk\/sq\/wp-json\/wp\/v2\/tags?post=2925"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}